Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and the Risk of Developing Rheumatoid Arthritis in Antihypertensive Patients

被引：0
|
作者：
de Jong, Hilda J. [1 ,2 ]
Vandebriel, Rob J. [1 ]
Saldi, Siti R. [3 ]
van Dijk, Liset [4 ]
van Loveren, Henk [1 ,2 ]
Tervaert, Jan Willem Cohen [2 ]
Klungel, Olaf H. [3 ]
机构：
[1] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands
[2] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[3] Univ Utrecht, Utrecht, Netherlands
[4] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
157
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [31] Which prevents diabetes better: Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Elliott, WJ
    Choi, KL
    Arano, KG
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 57A - 58A
  • [32] Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?
    Kaplan, NM
    JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (Suppl 1) : S87 - S90
  • [33] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on peritoneal transport Reply
    Nessim, Sharon J.
    Perl, Jeffrey
    Bargman, Joanne M.
    KIDNEY INTERNATIONAL, 2011, 79 (01) : 137 - 137
  • [34] Angiotensin II-receptor blockers: will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?
    NM Kaplan
    Journal of Human Hypertension, 2000, 14 : S87 - S90
  • [35] Effects of some angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on experimental inflammations
    Magyar, Ioan
    Cret, Mihai
    Cuparencu, Barbu
    FASEB JOURNAL, 2013, 27
  • [36] Antihypertensive therapy - Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and calcium antagonists
    Gifford, RW
    MEDICAL CLINICS OF NORTH AMERICA, 1997, 81 (06) : 1319 - &
  • [37] ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS AS A RISK FACTOR FOR PATIENTS HOSPITALIZED WITH COVID-19. IS THAT TRUE?
    Luque, Paula
    Castilla-Guerra, Luis
    Ferrary, Maria
    Sanchez, Nieves
    Alegre, Maria
    Carmona, Eduardo
    Angel Rico, Miguel
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E167 - E167
  • [38] Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
    Lai, Chih-Cheng
    Wang, Ya-Hui
    Wang, Cheng-Yi
    Wang, Hao-Chien
    Yu, Chong-Jen
    Chen, Likwang
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 867 - 874
  • [39] USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF DEMENTIA IN HEART FAILURE
    Chitnis, A. S.
    Johnson, M. L.
    Aparasu, R. R.
    Chen, H.
    Kunik, M. E.
    Schulz, P. E.
    VALUE IN HEALTH, 2013, 16 (03) : A11 - A11
  • [40] Use of Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Risk of Dementia in Heart Failure
    Chitnis, Abhishek S.
    Aparasu, Rajender R.
    Chen, Hua
    Kunik, Mark E.
    Schulz, Paul E.
    Johnson, Michael L.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (05): : 395 - 404
12345